Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells-Reference-Cited by-同舟云学术

Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells

Published:2021-06-29 Issue:9 Volume:112 Page:3722-3731
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Furuta Tomoaki¹²^ORCID,Oda Tatsuya¹^ORCID,Kiyoi Kayo²,Yusuke Ozawa¹,Kimura Sota¹^ORCID,Kurimori Ko¹,Miyazaki Yoshihiro¹,Yu Yang¹,Furuya Kinji¹,Akashi Yoshimasa¹,Shimomura Osamu¹,Tateno Hiroaki²

Affiliation:

1. Faculty of Medicine Department of Surgery, Clinical Sciences University of Tsukuba Tsukuba Japan

2. Cellular and Molecular Biotechnology Research Institute National Institute of Advanced Industrial Science and Technology (AIST) Tsukuba Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15023

Reference39 articles.

1. Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine

2. The glycocalyx and its significance in human medicine

3. Glycosylation in cancer: mechanisms and clinical implications

4. A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin–Drug Conjugate (LDC)

5. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target;Gastroenterology;2024-08

2. The role of gastric mucins and mucin‐related glycans in gastric cancers;Cancer Science;2024-07-19

3. Impact of single-residue mutations on protein thermal stability: The case of threonine 83 of BC2L-CN lectin;International Journal of Biological Macromolecules;2024-06

4. Delivery of a BET protein degrader via a CEACAM6-targeted antibody–drug conjugate inhibits tumour growth in pancreatic cancer models;Nature Communications;2024-03-11

5. Promising Highly Targeted Therapies for Cholangiocarcinoma: A Review and Future Perspectives;Cancers;2023-07-20